Shunts with blood-flow indicators

Information

  • Patent Grant
  • 11844893
  • Patent Number
    11,844,893
  • Date Filed
    Sunday, January 16, 2022
    2 years ago
  • Date Issued
    Tuesday, December 19, 2023
    4 months ago
Abstract
An apparatus for shunting blood includes a flow-indication chamber shaped to define an entry port and an exit port, and one or more moveable objects disposed within the flow-indication chamber and configured to move in response to a flowing of the blood from the entry port to the exit port. At least a portion of a wall of the flow-indication chamber is transparent so as to expose the moveable objects to sight. Other embodiments are also described.
Description
FIELD OF THE INVENTION

The present invention relates to medical procedures, such as procedures in which blood of a subject is shunted from one blood vessel to another.


BACKGROUND

In some procedures, blood is shunted from one blood vessel to another.


SUMMARY OF THE INVENTION

There is provided, in accordance with some embodiments of the present invention, an apparatus for shunting blood. The apparatus includes a flow-indication chamber shaped to define an entry port and an exit port, and one or more moveable objects disposed within the flow-indication chamber and configured to move in response to a flowing of the blood from the entry port to the exit port. At least a portion of a wall of the flow-indication chamber is transparent so as to expose the moveable objects to sight.


In some embodiments, the moveable objects include a plurality of beads.


In some embodiments, at least one of the beads includes multiple faces.


In some embodiments, each of the beads is coated with an anticoagulant.


In some embodiments, the moveable objects include a rotational member configured to rotate in response to the blood exerting a force on the rotational member.


In some embodiments, the rotational member includes a wheel including a plurality of spokes.


In some embodiments, the wheel is positioned relative to the entry port and exit port such that each of the spokes, when perpendicular to an unimpeded path of the blood from the entry port to the exit port, intersects the unimpeded path.


In some embodiments, a most proximal point on each of the spokes that intersects the unimpeded path is located between 50% and 80% of a length of the spoke from a proximal end of the spoke.


In some embodiments, the apparatus further includes a filter chamber configured to couple to the flow-indication chamber and to hold a blood filter in the filter chamber.


In some embodiments, the apparatus further includes a threaded ring,


the filter chamber is shaped to define a filter-chamber port,


the flow-indication chamber is configured to screw into a first side of the threaded ring, and


the filter chamber is configured to screw into a second side of the threaded ring such that the entry port or exit port is fluidly connected with the filter-chamber port.


In some embodiments, the flow-indication chamber is further configured to hold a blood filter therein.


In some embodiments, the apparatus further includes a valve configured to regulate the flowing of the blood through a port selected from the group of ports consisting of: the entry port, and the exit port.


In some embodiments, the valve includes:


a pushable element passing through a wall of the flow-indication chamber and configured to cover the port upon being pushed into the flow-indication chamber; and


a spring coupled to the pushable element and to an inner wall of the flow-indication chamber, and configured to inhibit the pushable element from covering the port in an absence of any pushing force applied to the pushable element.


In some embodiments, the spring includes a tension spring.


There is further provided, in accordance with some embodiments of the present invention, a method including coupling an upstream end of a first conduit to a source blood vessel of a subject and a downstream end of the first conduit to an entry port of a shunt. The method further includes coupling an upstream end of a second conduit to an exit port of the shunt and a downstream end of the second conduit to a sink blood vessel of the subject, such that blood flows from the source blood vessel to the sink blood vessel via the shunt, thus causing movement of one or more moveable objects disposed within the shunt, the movement being visible through a wall of the shunt.


In some embodiments, the shunt includes a flow-indication chamber, which contains the moveable objects, and a filter chamber, which is coupled to the flow-indication chamber and holds a blood filter in the filter chamber.


There is further provided, in accordance with some embodiments of the present invention, an apparatus including a chamber shaped to define a fluid port, a first appendage protruding from the chamber and shaped to define a first aperture and a first row of one or more teeth, and a second appendage protruding from the chamber and shaped to define a second aperture and a second row of one or more teeth parallel to the first row of teeth. The second row is configured to interlock with the first row at multiple different relative positions of the first appendage and second appendage in which the second aperture is aligned with the first aperture with different respective degrees of alignment such that a tube, which carries blood to or from the fluid port through the first aperture and second aperture, is constricted with different respective degrees of constriction.


In some embodiments, the chamber is configured to hold a blood filter therein.


In some embodiments, the apparatus further includes one or more moveable objects disposed within the chamber and configured to move in response to a flowing of the blood through the chamber, at least a portion of a wall of the chamber being transparent so as to expose the moveable objects to sight.


In some embodiments, the first appendage and second appendage are continuous with a wall of the chamber.


In some embodiments, the first appendage and second appendage are configured to revert to a default relative position, in which the tube is not constricted, upon a release of the first row and second row from one another.


In some embodiments,


the first appendage includes a first back arm, which protrudes from the chamber, and a first front arm, which is angled with respect to the first back arm and is shaped to define the first aperture and the first row of teeth, and


the second appendage includes a second back arm, which protrudes from the chamber, and a second front arm, which is angled with respect to the second back arm and is shaped to define the second aperture and the second row of teeth.


In some embodiments, each of the teeth in the first row and in the second row is angled backward, such that an advancement of the first row and second row relative to one another constricts the tube.


In some embodiments, the tube is not completely constricted in any of the positions.


There is further provided, in accordance with some embodiments of the present invention, a method including sliding a first appendage, which protrudes from a chamber and is shaped to define a first aperture and a first row of one or more teeth, across a second appendage, which protrudes from the chamber and is shaped to define a second aperture and a second row of one or more teeth parallel to the first row of teeth, such that the second row interlocks with the first row at a relative position of the first appendage and second appendage in which the second aperture is misaligned with the first aperture, thereby constricting a tube that carries blood to or from a fluid port of the chamber through the first aperture and second aperture. The method further includes, subsequently to constricting the tube, releasing the first row and second row from one another, thereby causing the first appendage and second appendage to revert to a default relative position in which the tube is not constricted.


The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1-3 are schematic illustrations of an apparatus for shunting blood, in accordance with some embodiments of the present invention; and



FIGS. 4A-B are schematic illustrations of a tube constrictor, in accordance with some embodiments of the present invention.





DETAILED DESCRIPTION OF EMBODIMENTS
Overview

In some cases, it may be necessary to shunt blood from one anatomical site to another. For example, during an operation to remove a clot from a carotid artery of a subject, it may be necessary to shunt blood from the carotid artery to a vein, such as a femoral vein, of the subject. In such cases, a shunting device (or “shunt”) is used to carry blood between the sites. However, there is a risk of the blood flow through the shunt slowing or stopping without the physician noticing.


To mitigate this risk, embodiments of the present invention provide a shunt comprising a flow-indication chamber containing one or more moveable objects, which are configured to move in response to the flow of blood through the flow-indication chamber. At least a portion of the wall of the flow-indication chamber is transparent, such that the moveable objects are visible. For example, the wall may comprise a transparent window, and the moveable objects may be disposed behind the window. Thus, a physician may readily check whether the blood is flowing properly through the shunt, by observing the degree of motion of the moveable objects.


In some embodiments, the moveable objects comprise multiple beads suspended in the blood, which rotate and/or change position as the blood flows. In other embodiments, the moveable objects comprise a wheel comprising a plurality of radiating spokes, which rotates as the blood flows across the spokes.


Another challenge is that sometimes it may be necessary to slow or stop the flow of blood through the shunt temporarily, e.g., to allow more blood to flow through the carotid artery to the brain of the subject.


To address this challenge, some embodiments of the present invention equip the shunt with a valve configured to control the rate of flow through the entry port or exit port of the shunt. For example, the valve may comprise a pushable element passing through the wall of the aforementioned flow-indication chamber, along with a spring within the flow-indication chamber, which couples the pushable element to an inner wall of the flow-indication chamber. In its resting state, the spring holds the pushable element away from the port, such that blood freely flows through the port. On the other hand, a pushing force sufficient to overcome the force of the spring may push the pushable element over the port, thereby slowing or stopping the flow of blood.


In other embodiments, the shunt is equipped with a tube constrictor configured to constrict the tube carrying the blood to or from the port. The tube constrictor comprises a pair of parallel arms, which are shaped to define respective apertures and respective rows of teeth. The rows of teeth are configured to interlock with one another at a default position, in which the apertures are aligned with one another, and at one or more other positions, in which the apertures are misaligned by varying degrees. Thus, while the tube passes through the apertures, the tube may be partially or fully constricted by sliding the arms over one another. Subsequently to constricting the tube, to resume regular blood flow, the rows of teeth may be released from one another such that the arms revert to their default positions.


Apparatus Description

Reference is initially made to FIG. 1, which is a schematic illustration of an apparatus 20 for shunting blood 22, in accordance with some embodiments of the present invention. An inset portion 44 of FIG. 1 shows part of the interior of apparatus 20.


Apparatus 20, which may be referred to as a “shunt,” comprises a flow-indication chamber 24 shaped to define an entry port 26 and an exit port 28. Blood 22 enters flow-indication chamber 24 via entry port 26, flows through the flow-indication chamber, and exits the flow-indication chamber via exit port 28.


In some embodiments, entry port 26 is configured to couple to an entry tube 30 (or any other entry conduit, such as a catheter) through which blood 22 flows to apparatus 20. For example, entry tube 30 may be fittingly inserted into entry port 26, or the entry port may be fittingly inserted into the entry tube.


In some embodiments, apparatus 20 further comprises a filter chamber 32 configured to couple to flow-indication chamber 24 and to hold a blood filter 34 in filter chamber 32. Blood filter 34 may be secured within the filter chamber using any suitable structural components, such as a plurality of ribs 86 as shown in FIG. 3, which is described below. Filter chamber 32 is shaped to define an entry port 38, through which blood 22 enters the filter chamber, and an exit port 40, through which the blood exits the filter chamber.


As shown in FIG. 1, the filter chamber may be coupled to the flow-indication chamber downstream from the flow-indication chamber, such that the blood flows through the filter chamber after flowing through the flow-indication chamber. (Optionally, a single common port may function as both exit port 28 and entry port 38.) In such embodiments, exit port 40 is configured to couple to an exit tube 42 (or any other exit conduit, such as a catheter), which carries the blood from apparatus 20.


Alternatively, the filter chamber may be coupled to the flow-indication chamber upstream from the flow-indication chamber. (Optionally, a single common port may function as both exit port 40 and entry port 26.) In such embodiments, entry port 38 of the filter chamber is configured to couple to entry tube 30, and exit port 28 of the flow-indication chamber is configured to couple to exit tube 42.


In some embodiments, apparatus 20 further comprises a threaded ring 36. Flow-indication chamber 24 is configured to screw into one side of threaded ring 36, and filter chamber 32 is configured to screw into the other side of the threaded ring such that the two chambers are in fluid communication with one another. For example, as shown in FIG. 1, the flow-indication chamber may be screwed into the upstream side of ring 36 and the filter chamber may be screwed into the downstream side of ring 36, such that the blood flows directly from exit port 28 into entry port 38. Alternatively, the filter chamber may be screwed into the upstream side of ring 36 and the flow-indication chamber may be screwed into the downstream side of ring 36, such that the blood flows directly from exit port 40 into entry port 26.


In other embodiments, as shown in FIG. 3, the flow-indication chamber and filter chamber are coupled to one another via a coupling tube 84.


In yet other embodiments, apparatus 20 does not comprise filter chamber 32. In such embodiments, flow-indication chamber 24 may be configured to hold blood filter 34 therein.


Apparatus 20 may shunt blood 22 between any two suitable blood vessels of a human or animal subject. In other words, apparatus 20 may shunt blood 22 from any suitable “source” blood vessel of the subject to any suitable “sink” blood vessel of the subject. For example, apparatus 20 may shunt blood from an artery of the subject to a vein of the subject, with entry tube 30 delivering blood from the artery and exit tube 42 carrying the blood to the vein. As a specific example, apparatus 20 may shunt blood from a carotid artery to a femoral vein during an operation to remove a clot from the carotid artery. Alternatively, apparatus 20 may shunt blood from a higher-pressure artery to a lower-pressure artery.


To deploy apparatus 20, the upstream end of entry tube 30 is coupled to the source blood vessel (e.g., via a stopcock and/or any other suitable equipment), and the downstream end of the entry tube is coupled to the entry port of apparatus 20 (e.g., entry port 26, for embodiments in which the flow-indication chamber is upstream from the filter chamber). Similarly, the upstream end of exit tube 42 is coupled to the exit port of apparatus 20 (e.g., exit port 40, for embodiments in which the flow-indication chamber is upstream from the filter chamber), and the downstream end of the exit tube is coupled to the sink blood vessel (e.g., via a stopcock and/or any other suitable equipment). Subsequently, blood flows from the source blood vessel to the sink blood vessel via apparatus 20.


Blood-Flow Indicators

Apparatus 20 further comprises one or more moveable objects 46 disposed within flow-indication chamber 24 and configured to move in response to the flowing of blood 22 from entry port 26 to exit port 28. At least a portion of the wall 52 of the flow-indication chamber is transparent so as to expose moveable objects 46 to sight. For example, wall 52 may be entirely transparent, as shown in FIG. 3 (described below). Alternatively, as shown in FIG. 1, the wall may comprise at least one transparent window 50. Thus, the physician may readily check the rate of blood flow through the flow-indication chamber, by observing the degree of movement of moveable objects 46. In some embodiments, the transparent portion of wall 52 comprises a magnifying lens, configured to magnify moveable objects 46.


In some embodiments, moveable objects 46 comprise a plurality of beads 48, which rotate and/or change position as the blood flows. Typically, beads 48 have a density less than that of blood 22, such that the beads remain suspended in the blood. Beads 48 may comprise any suitable hemocompatible material such as a metal, plastic, wood, latex, synthetic rubber, or any combination of the above.


In general, each of the beads may have any suitable shape. For example, beads 48 may comprise at least one spherical bead 48a. Alternatively or additionally, beads 48 may comprise at least one bead comprising multiple faces; such a bead may move more in response to the blood flow, relative to spherical bead 48a, due to the greater force applied to the bead by the blood. Example of beads comprising multiple faces include a cubical bead 48b and a pyramidical bead 48c.


In general, larger beads may be more noticeable than smaller beads; hence, in some embodiments, for each bead 48, the Cartesian distance between any two points on the outer surface of the bead is greater than 0.1 cm. Alternatively or additionally, for increased movement of the bead, the Cartesian distance between any two points on the outer surface of the bead may be less than 0.65 cm.


In some embodiments, each of the beads is coated with an anticoagulant, such as heparin.


In some embodiments, for greater visibility, the color of the beads contrasts with that of blood 22. Suitable contrasting colors include black, blue, and white. Alternatively, the beads may have any other color.


In some embodiments, exit port 28 is covered with a filter configured to inhibit any of the beads from passing through. Alternatively or additionally, as described above, filter chamber 32 may be coupled to the flow-indication chamber downstream from the flow-indication chamber, such that any beads that pass through exit port 28 are filtered from the blood by filter 34.


Reference is now made to FIG. 2, which is a schematic illustration of apparatus 20, in accordance with some embodiments of the present invention. An inset portion 58 of FIG. 2 shows part of the interior of apparatus 20.


In some embodiments, moveable objects 46 comprise a rotational member configured to rotate in response to the blood exerting a force on the rotational member.


For example, moveable objects 46 may comprise a wheel 54 comprising a plurality of spokes 56 (which may also be referred to as “radial members”) and configured to rotate in response to blood 22 exerting a force on spokes 56. For noticeability, the length of each spoke 56 may be greater than 0.6 cm, and/or the width of each spoke may be greater than 0.3 cm. Alternatively or additionally, to obviate the need for an overly large flow-indication chamber, the length of each spoke 56 may be less than 3.8 cm, and/or the width of each spoke may be less than 1.3 cm.


Using two dashed lines, inset portion 58 demarcates the unimpeded path 60 of the blood, i.e., the path from entry port 26 to exit port 28 that the blood would follow in the absence of wheel 54. Typically, wheel 54 is positioned relative to the entry and exit ports such that each spoke, when perpendicular to path 60 at any point along the path, intersects the path. Thus, the flow of blood through the flow-indication chamber generally keeps the wheel rotating in a single direction. For example, in FIG. 2, the wheel rotates clockwise, as indicated by a rotation indicator 55.


For example, denoting the end of the spoke closest to hub 62 as the proximal end of the spoke and the opposite end as the distal end of the spoke, the most proximal point on the spoke that intersects path 60 may be located between 50% and 80% of the length of the spoke from the proximal end of the spoke. (For example, if the spoke is 3 cm long, the most proximal point on the spoke that intersects path 60 may be located between 1.5 and 2.4 cm from the proximal end of the spoke.) Advantageously, this positioning of the wheel may increase the rotational force to which the wheel is subjected.


In some embodiments, the internal walls 61 of flow-indication chamber 24 constrict the space within the chamber in which the blood can flow, such that the blood follows path 60 at a greater speed and hence, applies greater force to the rotational member.


Typically, as shown in Section A-A, wheel 54 is mounted onto a shaft 64 (i.e., shaft 64 passes through hub 62), such that the wheel rotates about the shaft. Shaft 64 is coupled at each of its ends to wall 52.


The rotational member (e.g., wheel 54) may be any suitable color, including a color that contrasts with that of blood, as described above for beads 48 (FIG. 1).


In alternative embodiments, Doppler ultrasound is used to measure the rate of blood flow. For example, a fixture, shaped to define a socket, may be fitted over one of the tubes, and a standard Doppler ultrasound probe may be inserted into the socket.


Regulating Blood Flow

Reference is again made to FIG. 1.


In some embodiments, apparatus 20 further comprises a valve 66 configured to regulate the flow of blood through the flow-indication chamber. Thus, using valve 66, a physician may control the rate at which blood is shunted.


In some embodiments, valve 66 comprises a pushable element 68 passing through wall 52 and configured to cover entry port 26 or exit port 28 upon being pushed into the flow-indication chamber. Typically, a gasket 76 (made of rubber, for example) seals the aperture in wall 52 through which the pushable element passes, such that blood does not leak through the wall.


In such embodiments, valve 66 further comprises a spring 78 coupled to the pushable element (e.g., by virtue of being coupled to a ledge 82 coupled to the pushable element) and to an inner wall of the flow-indication chamber (e.g., the inside of wall 52). Spring 78 is configured to inhibit the pushable element from covering the entry port or exit port in the absence of any pushing force applied to the pushable element. Thus, to slow or stop the flow of blood, the physician must continuously exert a pushing force to counteract the force applied by the spring, such that the physician is unlikely to forget that the flow has been slowed or stopped.


Typically, as shown in FIG. 1, spring 78 comprises a tension spring 80. In the absence of any pushing force, spring 80 is maximally compressed, such that the tension spring holds the pushable element in its outermost position.


In some embodiments, pushable element 68 comprises a neck 70 and a foot 72, which protrudes from the end of neck 70 that is inside the flow-indication chamber. As neck 70 is pushed further into the flow-indication chamber, foot 72 covers a greater portion of the entry port or exit port, thereby slowing the flow of blood. Upon the neck being maximally pushed, foot 72 completely covers the port, such that the flow is stopped. Optionally, the opposite end of neck 70, which is outside the flow-indication chamber, may terminate at a head 74, which is wider than the neck and thus facilitates the pushing of the neck into the flow-indication chamber.


In other embodiments, valve 66 comprises a pullable element passing through wall 52 and configured to cover entry port 26 or exit port 28 upon being pulled.


(It is noted that valve 66 may also be combined with any other suitable embodiment of moveable objects 46, such as the embodiment of FIG. 2.)


Reference is now made to FIG. 3, which is a schematic illustration of apparatus 20, in accordance with some embodiments of the present invention.


In some embodiments, apparatus 20 comprises tube constrictor 88, which may also be referred to as a “locking clip.” Tube constrictor 88 comprises a first appendage 90a, shaped to define a first aperture 92a, and a second appendage 90b, shaped to define a second aperture 92b.


As further described below with reference to FIGS. 4A-B, tube constrictor 88 is configured to control the rate of blood flow through a tube passing through apertures 92a and 92b by constricting the tube with varying degrees of constriction. Thus, apparatus 20 need not necessarily comprise valve 66 (FIG. 1).


For example, tube constrictor 88 may provide two degrees of constriction: no (0%) constriction, and full (100%) or partial (e.g., 80%-90%) constriction. Alternatively, tube constrictor 88 may provide three or more degrees of constriction. An example of four degrees of constriction is 0%, 20%-40% (e.g., 33%), 60%-80% (e.g., 66%), and 90%-100%.


(In the context of the present application, including the claims, the tube may be considered to be constricted by x % if the rate of blood flow through the tube is x % of what the rate would be if the tube were not constricted at all.)


In some such embodiments, flow-indication chamber 24 is coupled to filter chamber 32 via coupling tube 84, and tube constrictor 88 is configured to constrict the coupling tube. For example, as shown in FIG. 3, first appendage 90a and second appendage 90b may protrude from filter chamber 32 in the upstream direction, i.e., the first and second appendages may protrude beyond entry port 38, and coupling tube 84 may carry blood to entry port 38 through the first and second apertures. Alternatively, the first and second appendages may protrude from flow-indication chamber 24 in the downstream direction, i.e., the first and second appendages may protrude beyond exit port 28, and coupling tube 84 may carry blood from exit port 28 through the first and second apertures.


In other such embodiments, tube constrictor 88 is configured to constrict entry tube 30. In other words, first appendage 90a and second appendage 90b protrude from flow-indication chamber 24 in the upstream direction, i.e., the first and second appendages protrude beyond entry port 26, and entry tube 30 carries blood to entry port 26 through the first and second apertures. (In this case, flow-indication chamber 24 may be coupled to filter chamber 32 as in FIGS. 1-2, or filter chamber 32 may be omitted.)


In yet other such embodiments, tube constrictor 88 is configured to constrict exit tube 42. In other words, first appendage 90a and second appendage 90b protrude from filter chamber 32 in the downstream direction, i.e., the first and second appendages protrude beyond exit port 40, and exit tube 42 carries blood from exit port 40 through the first and second apertures. (In this case, flow-indication chamber 24 may be coupled to filter chamber 32 as in FIGS. 1-2, or flow-indication chamber 24 may be omitted.)


For those embodiments in which apparatus 20 comprises flow-indication chamber 24, the flow-indication chamber may contain any suitable moveable objects 46, such as wheel 54 or beads 48 (FIG. 1).


In some embodiments, the first and second appendages are continuous with the wall of the chamber from which the appendages protrude, i.e., the wall extends beyond the chamber so as to define the appendages. In other embodiments, the appendages are coupled to the wall of the chamber, e.g., using any suitable adhesive.


Typically, each appendage comprises a back arm 100, which protrudes from the chamber, and a front arm 102, which is angled (e.g., at approximately 90 degrees) with respect to back arm 100 and is shaped to define the aperture through which the tube passes.


Reference is now made specifically to inset portion 110 of FIG. 3, which shows the back of front arm 102 of first appendage 90a, i.e., the surface of the front arm that faces second appendage 90b.


In addition to first aperture 92a, first appendage 90a (e.g., front arm 102 of the first appendage) is shaped to define a first row 94a of one or more teeth 96. Similarly, as shown in FIGS. 4A-B, second appendage 90b (e.g., front arm 102 of the second appendage) is shaped to define a second row 94b of one or more teeth 96 parallel to first row 94a. As further described below with reference to FIGS. 4A-B, second row 94b is configured to interlock with first row 94a at multiple different relative positions of the first appendage and second appendage. In these different positions, second aperture 92b is aligned with first aperture 92a with different respective degrees of alignment such that coupling tube 84 (or any other tube passing through the apertures) is constricted with different respective degrees of constriction.


Reference is now made to FIGS. 4A-B, which are schematic illustrations of tube constrictor 88, in accordance with some embodiments of the present invention.


In FIG. 4A, the first and second appendages are at a first relative position in which second aperture 92b is aligned with first aperture 92a, such that coupling tube 84 is not constricted. Subsequently, one or both of the appendages may be shifted such that the appendages assume a second relative position in which the two apertures are less aligned with one another, and hence tube 84 is mostly constricted, as shown in FIG. 4B.


In some embodiments, as shown in FIGS. 4A-B, each tooth 96 is angled backward (e.g., toward back arm 100 of the appendage), such that the tooth comprises a longer front edge 104 and a shorter back edge 106. In such embodiments, the tube may be constricted by advancing the two rows of teeth relative to one another, e.g., by pushing at least one front arm 102 toward the back arm 100 of the other appendage. For example, as indicated in FIG. 4A by pinch indicators 98, the appendages may be pinched together, e.g., using a forefinger placed on one back arm 100 and a thumb placed on the other back arm. As one or both of the rows are advanced, front edges 104 slide across each other, until the rows of teeth interlock at the next position by virtue of the contact between back edges 106, which inhibits the rows from sliding backward.


In other embodiments, each tooth 96 is angled forward, toward the tip of the appendage. In such embodiments, the tube may be constricted by moving at least one row of teeth backward relative to the other row of teeth, e.g., by pulling at least one front arm 102 away from the back arm 100 of the other appendage.


In some embodiments, the first and second appendages are configured to revert to a default relative position, in which the tube is not constricted, upon a release of first row 94a and second row 94b from one another, as indicated in FIG. 4B by release indicators 108. In other words, at least one of the appendages is elastic, such that any movement from the default relative position causes the appendage to store elastic energy that, upon release of the rows from one another, causes the appendage to revert to the default position. Alternatively or additionally, upon release, the first and second appendages may revert to their default relative position due to elastic energy stored in the wall of the tube while the tube is constricted.


(It is emphasized that the appendages may be shaped to define fewer teeth than are shown in the figures. For example, one appendage may be shaped to define a single tooth, and the other appendage may be shaped to define N≥2 teeth, such that N degrees of constriction are provided.)


Typically, the tube is not completely constricted in any of the positions in which the rows of teeth interlock with one another. In other words, as shown in FIG. 4B, even at the most constricted interlocked position, the tube may remain partly (e.g., 10%-20%) unconstricted. Thus, advantageously, full constriction of the tube requires that the physician continuously apply a force to one or both of the appendages, such that the physician is unlikely to forget that the flow has been stopped. For example, in the scenario shown in FIG. 4B, full constriction of the tube may require a continuous pinching of the appendages. In the absence of a pinching force, the elastic energy stored in the appendages and/or the wall of the tube causes the appendages to revert to the most constricted interlocked position.


(For embodiments in which the teeth are angled backward, the most constricted interlocked position is that in which the frontmost tooth of one appendage locks against the backmost tooth of the other appendage. For embodiments in which the teeth are angled forward, the most constricted interlocked position is that in which the frontmost tooth of one appendage locks against the frontmost tooth of the other appendage.)


Alternatively to tube constrictor 88, apparatus 20 may comprise any other clamp that protrudes from one of the chambers and is configured to constrict a tube in fluid communication with the chamber. The clamp may be continuous with the wall of the chamber from which the clamp protrudes, or coupled to the wall of the chamber.


It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of embodiments of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description. Documents incorporated by reference in the present patent application are to be considered an integral part of the application except that to the extent any terms are defined in these incorporated documents in a manner that conflicts with the definitions made explicitly or implicitly in the present specification, only the definitions in the present specification should be considered.

Claims
  • 1. Apparatus, comprising: a chamber shaped to define a fluid port;a first appendage protruding from the chamber and shaped to define a first aperture and a first row of one or more teeth; anda second appendage protruding from the chamber and shaped to define a second aperture and a second row of one or more teeth parallel to the one or more teeth of the first row,the first aperture and the second aperture are each configured for receiving a tube extending therethrough, the tube in communication with the fluid port,the one or more teeth of the second row being configured to interlock with the one or more teeth of the first row at multiple different relative positions of the first appendage and second appendage in which the second aperture is aligned with the first aperture with different respective degrees of alignment such that the tube is constricted with different respective degrees of constriction, controlling a rate of blood flow through the tube.
  • 2. The apparatus according to claim 1, wherein the chamber is configured to hold a blood filter therein.
  • 3. The apparatus according to claim 1, further comprising one or more moveable objects disposed within the chamber and configured to move in response to a flowing of the blood through the chamber, at least a portion of a wall of the chamber being transparent so as to expose the one or more moveable objects to sight.
  • 4. The apparatus according to claim 1, wherein the first appendage and second appendage are continuous with a wall of the chamber.
  • 5. The apparatus according to claim 1, wherein the first appendage and second appendage are configured to revert to a default relative position, in which the tube is not constricted, upon a release of the first row and second row from one another.
  • 6. The apparatus according to claim 1, wherein the first appendage comprises a first back arm, which protrudes from the chamber, and a first front arm, which is angled with respect to the first back arm and is shaped to define the first aperture and the one or more teeth of the first row, andwherein the second appendage comprises a second back arm, which protrudes from the chamber, and a second front arm, which is angled with respect to the second back arm and is shaped to define the second aperture and the one or more teeth of the second row.
  • 7. The apparatus according to claim 1, wherein each of the one or more teeth in the first row and in the second row is angled backward, such that an advancement of the first row and second row relative to one another constricts the tube.
  • 8. The apparatus according to claim 1, wherein the tube is not completely constricted in any of the positions.
  • 9. A method, comprising: sliding a first appendage, which protrudes from a chamber and is shaped to define a first aperture and a first row of one or more teeth, across a second appendage, which protrudes from the chamber and is shaped to define a second aperture and a second row of one or more teeth parallel to the first row of teeth, such that the one or more teeth of the second row interlocks with the one or more teeth of the first row at a relative position of the first appendage and second appendage in which the second aperture is misaligned with the first aperture, thereby constricting a tube extending through the first aperture and the second aperture and is in communication with a fluid port of the chamber to control a rate of blood flow through the tube; andsubsequently to constricting the tube, releasing the one or more teeth of the first row and the one or more teeth of the second row from one another, thereby causing the first appendage and second appendage to revert to a default relative position in which the tube is not constricted.
  • 10. The method according to claim 9, wherein the chamber holds a blood filter therein.
  • 11. The method according to claim 9, wherein one or more moveable objects are disposed within the chamber and are configured to move in response to a flowing of the blood through the chamber, at least a portion of a wall of the chamber being transparent so as to expose the one or more moveable objects to sight.
  • 12. The method according to claim 9, wherein the first appendage and second appendage are continuous with a wall of the chamber.
  • 13. The method according to claim 9, wherein the first appendage includes a first back arm, which protrudes from the chamber, and a first front arm, which is angled with respect to the first back arm and is shaped to define the first aperture and the one or more teeth of the first row, andwherein the second appendage includes a second back arm, which protrudes from the chamber, and a second front arm, which is angled with respect to the second back arm and is shaped to define the second aperture and the one or more teeth of the second row.
  • 14. The method according to claim 9, wherein each of the one or more teeth in the first row and in the second row is angled backward, and wherein sliding the first appendage across the second appendage comprises advancing the first row and second row relative to one another.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims the benefit of U.S. Provisional Application 63/138,451, entitled “Visualization of blood flow in a venous/arterial shunting system,” filed Jan. 17, 2021, whose disclosure is incorporated herein by reference.

US Referenced Citations (138)
Number Name Date Kind
3641994 Gosling et al. Feb 1972 A
4559034 Kirita et al. Dec 1985 A
4661097 Fischell et al. Apr 1987 A
4874359 White et al. Oct 1989 A
5374239 Mischenko Dec 1994 A
5395105 Thommen, Jr. Mar 1995 A
5601572 Middleman Feb 1997 A
5843244 Pelton et al. Dec 1998 A
6019772 Shefaram et al. Feb 2000 A
6019778 Wilson et al. Feb 2000 A
6109406 Takagi et al. Aug 2000 A
6129755 Mathis et al. Oct 2000 A
6206868 Parodi Mar 2001 B1
6235042 Katzman May 2001 B1
6295989 Connors, III Oct 2001 B1
6312454 Stoeckel et al. Nov 2001 B1
6312455 Duerig et al. Nov 2001 B2
6413235 Parodi Jul 2002 B1
6423032 Parodi Jul 2002 B2
6425898 Wilson et al. Jul 2002 B1
6503271 Duerig et al. Jan 2003 B2
6540712 Parodi et al. Apr 2003 B1
6582396 Parodi Jun 2003 B1
6632236 Hogendijk Oct 2003 B2
6641573 Parodi Nov 2003 B1
6645222 Parodi et al. Nov 2003 B1
6682505 Bates et al. Jan 2004 B2
6689084 Kaganov et al. Feb 2004 B2
6743219 Dwyer et al. Jun 2004 B1
6773446 Dwyer et al. Aug 2004 B1
6859986 Jackson et al. Mar 2005 B2
6863685 Davila et al. Mar 2005 B2
6905490 Parodi Jun 2005 B2
6908474 Hogendijk et al. Jun 2005 B2
6935404 Duerig et al. Aug 2005 B2
6936060 Hogendijk et al. Aug 2005 B2
6942688 Bartholf et al. Sep 2005 B2
7063685 Rome Jun 2006 B2
7344527 Schweikert et al. Mar 2008 B2
7879011 Chang Feb 2011 B2
7927347 Hogendijk et al. Apr 2011 B2
7998104 Chang Aug 2011 B2
8002728 Chang Aug 2011 B2
8157760 Criado et al. Apr 2012 B2
8235943 Breznock et al. Aug 2012 B2
8308709 Chang Nov 2012 B2
8343089 Chang Jan 2013 B2
8414516 Chang Apr 2013 B2
8444586 Beck May 2013 B2
8545432 Renati et al. Oct 2013 B2
8545552 Garrison et al. Oct 2013 B2
8574245 Garrison et al. Nov 2013 B2
8740834 Criado et al. Jun 2014 B2
8784355 Criado et al. Jul 2014 B2
8858490 Chou et al. Oct 2014 B2
8870805 Chang Oct 2014 B2
9011364 Criado et al. Apr 2015 B2
9011467 Garrison et al. Apr 2015 B2
9084857 Cully et al. Jul 2015 B2
9126018 Garrison Sep 2015 B1
9138527 Renati et al. Sep 2015 B2
9179909 Garrison et al. Nov 2015 B2
9241699 Kume et al. Jan 2016 B1
9259215 Chou et al. Feb 2016 B2
9265512 Garrison et al. Feb 2016 B2
9295817 Chang Mar 2016 B2
9399118 Kume et al. Jul 2016 B2
9427305 Kuraguntla et al. Aug 2016 B2
9492637 Garrison et al. Nov 2016 B2
9526504 Chang Dec 2016 B2
9561345 Garrison et al. Feb 2017 B2
9623228 Ryan et al. Apr 2017 B2
9655755 Chou et al. May 2017 B2
9662118 Chang May 2017 B2
9662480 Kume et al. May 2017 B2
9668743 Cully et al. Jun 2017 B2
9669183 Chang Jun 2017 B2
9669191 Chou et al. Jun 2017 B2
9693789 Garrison et al. Jul 2017 B2
9789242 Criado et al. Oct 2017 B2
9820761 Garrison et al. Nov 2017 B2
9833555 Criado et al. Dec 2017 B2
9861783 Garrison et al. Jan 2018 B2
10039906 Kume et al. Aug 2018 B2
10085864 Chou et al. Oct 2018 B2
10159479 Hentges et al. Dec 2018 B2
10182801 Garrison Jan 2019 B2
10188399 Chang Jan 2019 B2
10226563 Garrison et al. Mar 2019 B2
10226598 Chou et al. Mar 2019 B2
10238853 Kume et al. Mar 2019 B2
10272269 Garrison et al. Apr 2019 B2
10286139 Criado et al. May 2019 B2
10327790 Garrison et al. Jun 2019 B2
10328232 Chang Jun 2019 B2
10357242 Garrison et al. Jul 2019 B2
10369346 Ryan et al. Aug 2019 B2
10384034 Garrison et al. Aug 2019 B2
10390847 Garrison et al. Aug 2019 B2
10426497 Chou et al. Oct 2019 B2
10426885 Criado et al. Oct 2019 B2
10485917 Criado et al. Nov 2019 B2
10543307 Criado et al. Jan 2020 B2
10709832 Criado et al. Jul 2020 B2
10722239 Chang Jul 2020 B2
10779835 Chang Sep 2020 B2
10779855 Garrison Sep 2020 B2
10799244 Cully et al. Oct 2020 B2
10799669 Chou et al. Oct 2020 B2
10828460 Chang Nov 2020 B2
10864357 Kume et al. Dec 2020 B2
10881393 Hentges et al. Jan 2021 B2
10918504 Wallace et al. Feb 2021 B2
10925709 Rogers et al. Feb 2021 B2
10939929 Garrison et al. Mar 2021 B2
10952882 Chou et al. Mar 2021 B2
10973502 Garrison Apr 2021 B2
11020133 Wilson et al. Jun 2021 B2
11027104 Kume et al. Jun 2021 B2
11097132 Garrison et al. Aug 2021 B2
11103627 Garrison et al. Aug 2021 B2
11141259 MacDonald et al. Oct 2021 B2
20010047184 Connors, III Nov 2001 A1
20020087119 Parodi Jul 2002 A1
20070055296 Stergiopulos Mar 2007 A1
20100204684 Garrison et al. Aug 2010 A1
20110004147 Renati et al. Jan 2011 A1
20130041305 Tarlian, Jr. et al. Feb 2013 A1
20130317409 Cully et al. Nov 2013 A1
20140296769 Hyde et al. Oct 2014 A1
20160242764 Garrison et al. Aug 2016 A1
20190344058 Hakim Nov 2019 A1
20190351182 Chou et al. Nov 2019 A1
20190358443 Lopez et al. Nov 2019 A1
20200292367 Elizalde Sep 2020 A1
20200397472 MacDonald et al. Dec 2020 A1
20210145453 Kume May 2021 A1
20210298929 Wallace et al. Sep 2021 A1
Foreign Referenced Citations (18)
Number Date Country
100534392 Sep 2009 CN
2497520 Sep 2012 EP
2005051206 Jun 2005 WO
2009012473 Jan 2009 WO
2009100210 Aug 2009 WO
2010075445 Jul 2010 WO
2013022796 Feb 2013 WO
2015100178 Jul 2015 WO
2016018781 Feb 2016 WO
2016036660 Mar 2016 WO
2016164606 Oct 2016 WO
2016176409 Nov 2016 WO
2018017981 Jan 2018 WO
2018156574 Aug 2018 WO
2019010077 Jan 2019 WO
2021087363 May 2021 WO
2021087480 May 2021 WO
2022201081 Sep 2022 WO
Non-Patent Literature Citations (19)
Entry
Sherif, “Homemade TCAR with Flow Reversal for Primary Proximal Carotid Artery Aneurisms in a Patent with Crescendo TIAS post neck operation,” Linkedin post, pp. 1-2, year 2021, as downloaded from https://www.linkedin.com/posts/profsherifsultan_nuig-tcar-cast-activity-6710036851517902848-Qwzw.
Silk Road Medical, Inc., “Enroute Transcarotid Neuroprotection System”, Manual, pp. 1-20, Mar. 7, 2020, year 2022, as downloaded from file:///C:/Users/Miriam/Downloads/_https___silkroadmed.com_wp-content_uploads_2020_09_11858.7-ENROUTE-NPS-IFU-US-ARTWORK1%20(1).pdf.
Parodi et al., “Cerebral Protection During Carotid Stenting Using Flow Reversal,” Journal of Vascular Surgery, vol. 41, No. 3, pp. 416-422, year 2005.
Perez-Grueso et al., “Angioplastia y Stenting Carotideo por Miniacceso Cervical y Flujo Invertido,” Angiologia, vol. 56, supl. 1, pp. S225-S234, year 2004.
Luk et al., “Transcarotid Artery Revascularization as a New Modality of Treatment for Carotid Stenosis,” Journal Pre-proof, Annals of Vascular Surgery, Elsevier Inc., pp. 1-14, year 2019.
Chang et al., “A New Approach to Carotid Angioplasty and Stenting with Transcervical Occlusion and Protective Shunting: Why it May be a Better Carotid Artery Intervention,” Journal of Vascular Surgery, vol. 39, No. 5, pp. 994-1002, May 2004.
Lin et al., “Protected Carotid Artery Stenting and Angioplasty via Transfemoral versus Transcervical Approaches,” Vascular and Endovascular Surgery, vol. 39, No. 6, pp. 499-503, year 2005.
Silk Road Medical, “TransCarotid Artery Revascularization (TCAR),” Product Overview, pp. 1-6, year 2022, as downloaded from https://silkroadmed.com/patient-caregivers/the-tcar-procedure/.
Rhodes et al., “Arteriovenous Shunt Measurements in Extremities,” Journal of Nuclear Medicine, vol. 13, No. 6, pp. 357-362, year 1972.
“Qosina—Medical Device Components/OEM Components,” product catalogue, Qosina Corp., USA, Qosina Europe Srl., Italy, pp. 1-4, year 2022, as downloaded from https://www.qosina.com/.
International Application PCT/IB2022/052688 filed Mar. 24, 2022.
Drake et al., U.S. Appl. No. 63/211,025, filed Jun. 16, 2021.
Inspiremd, “Sustained Embolic Protection”, pp. 1-23, Jul. 8, 2020, as downloaded from https://www.inspiremd.com/en/wp-content/uploads/InspireMD-Investor-Deck-Revised-July-8-2020_compressed.pdf.
Sherif, “The TCAR Procedure: Transcervical carotid Artery Revascularization and stenting by C-Guard”, Linkedin post, p. 1-1, year 2021, as downloaded from https://www.linkedin.com/feed/update/urn:li:activity:6689646427859140608/.
International Application # PCT/IB2022/050329 Search Report dated May 10, 2022.
International Application # PCT/IBB2022/052688 Search Report dated Jul. 7, 2022.
Saint-Gobain Performance Plastics Corporation, “TYGON Medical/Surgical Tubing S-50-HL,” pp. 1-2, year 2004.
Silk Road Medical Inc., “ENHANCE Transcarotid Peripheral Access Kit,” pp. 1-2, Dec. 28, 2018.
Silk Road Medical Inc., “ENROUTE Transcarotid Stent System,” pp. 1-4, May 27, 2021.
Related Publications (1)
Number Date Country
20220226556 A1 Jul 2022 US
Provisional Applications (1)
Number Date Country
63138451 Jan 2021 US